Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma

DNA and Cell Biology

Volumn 30, Issue 12, 2011, Pages 1051-1055

  Liu, Yang ^a   He, Zhimin ^b   Feng, Dapeng ^a   Shi, Guodong ^a   Gao, Rui ^a   Wu, Xiaodong ^a   Song, Weiguo ^c   Yuan, Wen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Shanghai No 6 People's Hospital   (China)

^c Shandong Academy of Chinese Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ALLELES; BONE NEOPLASMS; CASE-CONTROL STUDIES; CHILD; CHINA; CHROMOSOMES, HUMAN, PAIR 2; CTLA-4 ANTIGEN; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; OSTEOSARCOMA; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 82955170680     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1269     Document Type: Article

References (20)

1. Bielack, S.S., Kempf-Bielack, B., Delling, G., Exner, G.U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., Zoubek, A., Jürgens, H., and Winkler, K. (2002). Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20, 776-790. (Pubitemid 34111386)
2. Bouqbis, L., Izaabel, H., Akhayat, O., Pérez-Lezaun, A., Calafell, F., Bertranpetit, J., and Comas, D. (2003). Association of the CTLA-4 promoter region (-1661G alleles) with type 1 diabetes in the south Moroccan population. Genes Immun 4, 132-137. (Pubitemid 38967587)
3. Contardi, E., Palmisano, G.L., Tazzari, P.L., Martelli, A.M., Falà , F., Fabbi, M., Kato, T., Lucarelli, E., Donati, D., Polito, L., Bolognesi, A., Ricci, F., Salvi, S., Gargaglione, V., Mantero, S., Alberghini, M., Ferrara, G.B., and Pistillo, M.P. (2005). CTLA-4 is constitutively expressed on tumor cells and can trigger ap-optosis upon ligand interaction. Int J Cancer 117, 538-550. (Pubitemid 41504541)
4. Dahlin, D.C., and Coventry, M.B. (1967). Osteogenic sarcoma: A study of six hundred cases. J Bone Joint Surg Am 49, 101-110.
5. Egen, J.G., Kuhns, M.S., and Allison, J.P. (2002). CTLA-4: new insights into its biological function and use in tumor immu-notherapy. Nat Immunol 3, 611-618. (Pubitemid 34752469)
6. Erfani, N., Razmkhah, M., Talei, A.R., Pezeshki, A.M., Dor-oudchi, M., Monabati, A., and Ghaderi A. (2006). Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. Cancer Genet Cytogenet 165, 114-120. (Pubitemid 43343504)
7. Feugeas, O., Guriec, N., Babin-Boilletot, A., Marcellin, L., Simon, P., Babin, S., Thyss, A., Hofman, P., Terrier, P., Kalifa, C., Brunat-Mentigny, M., Patricot, L.M., and Oberling, F. (1996). Loss of heterozygosity in the RB gene is a poor prognostic factor in patients with osteosarcoma. J Clin Oncol 14, 467-472. (Pubitemid 26051009)
8. Hadinia, A., Hossieni, S.V., Erfani, N., Saberi-Firozi, M., Fattahi, M.J., and Ghaderi, A. (2007). CTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colo-rectal cancers. J Gastroenterol Hepatol 22, 2283-2287. (Pubitemid 350145629)
9. Heinsohn, S., Evermann, U., Stadt, U.Z., Bielack, S., and Kabisch, H. (2007). Determination of the prognostic value of loss of heterozygosity at the retinoblastoma gene in osteosarcoma. Int J Oncol 30, 1205-1214.
10. Ligers, A., Teleshova, N., Masterman, T., Huang, W.X., and Hil-lert, J. (2001). CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2, 145-152. (Pubitemid 33674879)
11. Nagamori, M., Kawaguchi, S., Murakami, M., Wada, T., Na-goya, S., Yamashita, T., Inobe, M., and Uede, T. (2002). Intrinsic and extrinsic manipulation of B7/CTLA-4 interaction for induction of anti-tumor immunity against osteosarcoma cells. Anticancer Res 22, 3223-3227. (Pubitemid 36070096)
12. Niswander, L.M., and Kim, S.Y. (2010). Stratifying osteosarco-ma: minimizing and maximizing therapy. Curr Oncol Rep 12, 266-270.
13. Ries, L.A.G., Smith, M.A., Gurney, J.G., Linet, M., Tamra, T., Young, J.L., Bunin, G.R. (1999). Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. National Cancer Institute, Seer Program: NIH Pub 99-4649.
14. Shi, Y.Y., and He, L. (2005). SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15, 97-98. (Pubitemid 41653949)
15. Strahm, B., and Malkin, D. (2006). Hereditary cancer predisposition in children: genetic basis and clinical implications. Int J Cancer 119, 2001-2006. (Pubitemid 44423655)
16. Teft, W.A., Kirchhof, M.G., and Madrenas, J. (2006). A molecular perspective of CTLA-4 function. Annu Rev Immunol 24, 65-97.
17. Ueda, H., Howson, J.M., Esposito, L., Heward, J., Snook, H., Chamberlain, G., Rainbow, D.B., Hunter, K.M., Smith, A.N., Di Genova, G., Herr, M.H., Dahlman, .I, Payne, F., Smyth. D., Lowe, C., Twells, R.C., Howlett, S., Healy, B., Nutland, S., Rance, H.E., Everett, V., Smink, L.J., Lam, A.C., Cordell, H.J., Walker, N.M., Bordin, C., Hulme, J., Motzo, C., Cucca, F., Hess, J.F., Metzker, M.L., Rogers, J., Gregory, S., Alla-habadia, A., Nithiyananthan, R., Tuomilehto-Wolf, E., Tuo-milehto, J., Bingley, P., Gillespie, K.M., Undlien, D.E., Rønningen, K.S., Guja, C., Ionescu-Tîrgovi̧ste, C., Savage, D.A., Maxwell, A.P., Carson, D.J., Patterson, C.C., Franklyn, J.A., Clayton, D.G., Peterson, L.B., Wicker, L.S., Todd, J.A., and Gough, S.C. (2003). Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506-511. (Pubitemid 36648570)
18. Wadayama, B.I., Toguchida, J., Shimizi, T. Ishizaki, K., Sasaki, M.S., Kotoura, Y., and Yamamuro, T. (1994). Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 54, 3042-3048. (Pubitemid 24187793)
19. Wong, Y.K., Chang, K.W., Cheng, C.Y., and Liu, C.J. (2006). Association of CTLA-4 gene polymorphism with oral squa-mous cell carcinoma. J Oral Pathol Med 35, 51-54.
20. Xiao, M., Qi, F., Chen, X., Luo, Z., Zhang, L., Zheng, C., Hu, S., Jiang, X., Zhou, M., and Tang, J. (2010). Functional polymorphism of cytotoxic T-lymphocyte antigen 4 and nasopharyn-geal carcinoma susceptibility in a Chinese population. Int J Immunogenet 37, 27-32.